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304Objective: It is important for coronary active perfusion systems to avoid myocardial ischemia during off-pump
coronary artery bypass grafting. We have developed a new concept for a perfusion system to pump blood based
on changes in helium gas volume. This system uses a conventional intra-aortic balloon pump to activate the
perfusion pump. Our study used basic and animal experiments to investigate the most suitable system for
coronary perfusion using this new concept.
Methods: A conventional intra-aortic balloon pump was used to supply power. A device for perfusion was
developed with a balloon placed inside a stiff syringe barrel. The device was connected to the helium gas
line of the intra-aortic balloon pump. Changes in flow with changes in augmentation level were noted when
volumes outside and within the balloon were changed. Six pigs with occlusion of the left anterior descending
artery were used for system validation, with monitoring to identify changes in hemodynamics and cardiac
enzyme levels.
Results: In the basic experiment, an 80-mL outside volume and 3.0-mL inner volume resulted in the greatest
percentage change in flow rate with respect to changes in augmentation. In the animal experiment, the new
coronary active perfusion system prevented myocardial ischemia during coronary occlusion.
Conclusions: We clarified the most suitable method for our new coronary active perfusion system. Using this
system, safe anastomosis was consistently performed in animal experiments. Clinically, off-pump coronary
artery bypass may potentially be performed more safely and easily using this new system. (J Thorac Cardiovasc
Surg 2014;148:304-10)Off-pump coronary artery bypass grafting (OPCAB) has
emerged as a promising technique for the treatment of
ischemic heart disease. However, the procedure requires
occluding the target coronary artery to maintain a bloodless
surgical field during anastomosis. Myocardial ischemia
may thus occur, resulting in hemodynamic instability and
arrhythmias during anastomosis. Such instability will
inevitably require conversion to cardiopulmonary bypass.1
In addition, retraction and stabilization during OPCAB
often cause systemic hypotension, particularly when the
heart is displaced vertically to expose the lateral and
posterior vessels.2 With OPCAB, the target vessel needs
to be perfused during anastomosis.
Several clinical studies have demonstrated the effective-
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These approaches are advantageous in terms of both cost
and ease of setup, but offer little benefit and may even
endanger patients with severe proximal coronary artery
stenosis or severe ischemic heart disease. It remains
unclear how the adequacy of blood flow is affected by
these passive shunts when systemic blood pressure
deteriorates during retraction or compression of the heart
during OPCAB.5
As mentioned earlier, there are some limits to passive
coronary perfusion. We have therefore been studying active
coronary perfusion systems since 2000. Over the course of
10 years, we developed a coronary active perfusion system
(CAPS) to supply sufficient blood to the myocardium
during OPCAB.6,7 With our CAPS, oxygenated blood is
supplied from the femoral artery and perfused by a pump
to optimize blood flow to the myocardium, and the
volume of blood supplied is independent of hemodynamic
status during the procedure. However, the system requires
a special pump, controller, and power supply system,
making it difficult to use. For that reason, use of this
procedure has not yet become popular.
We have developed a new concept for a perfusion system
to pump blood based on changes in helium gas volume. This
system uses a conventional intra-aortic balloon pumpery c July 2014
Abbreviations and Acronyms
CAPS ¼ coronary active perfusion system
CK ¼ creatine kinase
IABP ¼ intra-aortic balloon pump
LAD ¼ left anterior descending coronary artery
OPCAB¼ off-pump coronary artery bypass grafting
Kiuchi et al Evolving Technology/Basic Science(IABP) to activate the perfusion pump, replacing our
former CAPS system. Our study involved basic and animal
experiments to clarify the most suitable system for coronary
perfusion using this new concept.E
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Basic Study of the New CAPS
Power supply. The conventional IABP (Datascope CS100; Maquet,
Fairfield, NJ) used in the experiments was originally a device to assist
cardiac function in synchrony with a patient’s heartbeat. Augmentation
changes the volume of helium gas, inflating the balloon at the end. The
IABP was tested to see if flow could be adjusted by changing the level
of augmentation. The IABP was set to auto mode, and synchronization
was set to internal mode (at a fixed rate of 60 bpm).
Device for perfusion. A device for perfusion was developed with a
balloon made of pliant, readily contracting urethane placed inside a stiff
syringe barrel made of acrylic (Figure 1, A). The balloon pump was
connected to the helium gas line of the IABP. The balloon passively
deflated as a result of changes in the pressure inside the syringe that
were synchronized to the patient’s electrocardiogram. A tube with a
directional valve was connected to each end of the balloon. Passive
deflation of the balloon pumped blood in a single direction (returning
drained blood) during diastole (Figure 1, B and C). We named this new
device the ‘‘booster shunt.’’
Flow was measured with a volume of outside space (in actuality, this
included the volume of the 2-m-long tube connecting the pump to
the IABP) of 60 mL, 80 mL, or 100 mL. The volume of outside space is
the capacity indicated in Figure 1, B and C. Changes in this volume result
in changes in the pressure within the syringe barrel, causing changes in
passive deflation of the balloon.
Flow was measured with a volume of the inner balloon of 1.0 mL,
2.0 mL, or 3.0 mL. Volume of the inner balloon is indicated in Figure 1,
B and C. This volume is closely related to the amount by which the balloon
is inflated with 1 beat of the heart.
Changes in flow in accordance with changes in augmentation level were
noted when the volumes of the outside space and inner balloon were
changed.
Coronary cannula. The cannula (CS150M; Forte Grow Medical,
Tochigi, Japan) is the same coronary cannula used in the former CAPS
at our facility, as previously reported.6,7 The enlarged, fixed portion of
the cannula can prevent back-bleeding from the arteriotomy site when it
is larger than the coronary artery being perfused. Flow was measured using
a cannula with an external diameter of 1.5 mm and an inner diameter of
0.6 mm, and a new cannula with an external diameter of 1.5 mm and inner
diameter of 0.8 mm.
Measurement. A 30% glycerin solution (liquid temperature, 37C)
was used to simulate blood. The IABP was in auto mode with a rate of
60 bpm. Augmentation was changed from level 1 to level 9. The
aforementioned volume of the outside space (60 mL, 80 mL, or 100 mL)
and volume of the inner balloon (1.0 mL, 2.0 mL, or 3.0 mL) in the
perfusion device were changed. Flow rate was measured using 2 different
coronary cannula inner diameters (0.6 mm and 0.8 mm). Flow rate wasThe Journal of Thoracic and Cameasured at different augmentation levels. To ascertain the percentage
increase in flow rate as augmentation changed, flow rate with augmentation
at level 1 was set as 100%. Percent changes in flow rate with different
levels of augmentation were then determined.
Animal Experiment
All animal studies were approved by the Institutional Animal Care and
Use Committee at Kanazawa University School of Medicine, and were
performed in accordance with the Principles of Laboratory Animal Care
formulated by the National Society for Medical Research and the Guide
for the Care and Use of Laboratory Animals prepared by the Institute of
Laboratory Animal Resources of the National Research Council, published
by the National Academies Press, and revised in 2010.
Six pigs with occlusion of the left anterior descending coronary artery
(LAD) were used to validate the new coronary perfusion system. The
6 pigs had a mean  standard deviation body weight of 45.3  5.4 kg
and a mean  standard deviation hemoglobin level of 12.5  2.4 g/dL.
Pigs were placed in the supine position, sedated by intramuscular
injection of ketamine (20 mg/kg body weight), and intubated with a 7.0F
endotracheal tube via tracheotomy. Anesthesia was maintained with
halothane (0.5%-1.5%), and muscle relaxation was induced with
pancuronium (0.1 mg/kg), administered via a peripheral intravenous route.
An arterial pressure line was inserted into the right brachiocephalic artery
through the right carotid artery. A 5F catheter was inserted into the right
femoral artery to pump out arterial blood for the perfusion system.
Median sternotomy was performed, the pericardium was incised
longitudinally, and pericardial purse-string sutures were placed to expose
the heart. After systemic heparinization (200 U/kg), the LAD was snared
at a point just distal to the first diagonal branch, and coronary arteriotomy
was performed. A coronary perfusion cannula was then inserted through
the arteriotomy site. To prevent the release of pressure from the arteriotomy
site, a site distal to the arteriotomy was snared. Arterial blood was passed
through extension tubes and pumped out by the booster shunt to perfuse the
LAD site (Figure 2).
Coronary perfusion was performed for 60 minutes, and hemodynamic
and mechanical data were recorded. Flow was measured with a flow meter
(VeriQ; MediStim, Oslo, Norway) at a point 2 cm distal to the site of
cannula insertion. Previous reports have cited a native coronary flow of
about 25 mL/min in the distal portion of the LAD. If this flow can be
maintained and cardiac function is unaffected, myocardial ischemia should
not occur.8 A cannula with an inner diameter of 0.6 mmwas used, based on
the results of these basic experiments. The IABP was in auto mode and
synchronized with the subject’s electrocardiogram. Peripheral perfusion
was provided at augmentation level 9 while the LAD was ligated.
Levels of creatine kinase (CK)-MB iso-enzyme and presence of
troponin T were also determined every 15 minutes to assess if distal
myocardial ischemia was present.
The end point of this study was 60 minutes of observation without
ventricular arrhythmia.
At the end of the experiment, all pigs were administered a lethal
intravenous injection of potassium chloride.
Statistical Analysis
Statistical analyses were performed using SPSS for Windows version
19.3J software (IBM-SPSS Inc, Armonk, NY). Cumulative data are
expressed as mean  standard deviation. Repeated-measures analysis
of variance (ANOVA) was used to compare flow rates among the augmen-
tations. Two-way ANOVA was used to compare percentage increases in
flow rate among the 3 groups (60 mL, 80 mL, and 100 mL; 1.0 mL, 2.0
mL, and 3.0 mL), followed by Bonferroni correction for the adjustment
of multiple comparisons. The percent increase in flow rate was expressed
as the ratio of the value to that with augmentation level 1. One-way
ANOVA was used to analyze changes in hemodynamics, coronary
perfusion flow, and CK-MB levels. All reported P values were 2-sided.rdiovascular Surgery c Volume 148, Number 1 305
FIGURE 1. Schema of the newly developed perfusion device (booster shunt). A, The booster shunt. B, Schema of the systolic phase. C, Schema of the
diastolic phase. IABP, Intra-aortic balloon pump.
Evolving Technology/Basic Science Kiuchi et al
E
T
/B
SRESULTS
Basic Study of the Booster Shunt
Figure 3 shows changes in flow rate due to increased or
decreased augmentation when the volume of outside space
was changed. Changes in flow rate and percent increases inFIGURE 2. Schema of the animal experiment. IABP, Intra-aortic balloon
pump.
306 The Journal of Thoracic and Cardiovascular Surgflow rate were seen when a cannula with inner diameter of
0.6 mm (Figure 3, A and C) or 0.8 mm (Figure 3, B and D)
was used.
Repeated-measures ANOVA showed that in both
instances, volumes of outside space of 80 mL resulted in
significantly greater changes in flow rate with respect to
increased augmentation than those seen with a 60- or
100-mL volume of outside space (Figure 3, A and B). In
both instances, flow rate did not alter with changes in
augmentation when the volume of outside space was
100 mL. Two-way ANOVA showed that with augmentation
levels 5 through 9, both cannulae with inner diameters of
0.6 mm and 0.8 mm resulted in significantly greater flow
rates with an 80-mL volume of outside space than with
60- and 100-mL volumes (Figure 3, C and D).
Figure 4 shows changes in flow rate due to increased
augmentation when the volume of the inner balloon was
changed. Measurements of flow rate and percent increase
in flow rate are indicated for the cannulae with an inner
diameter of 0.6 mm (Figure 4, A and C) and 0.8 mm
(Figure 4, B and D).
Repeated-measuresANOVAshowed that in both instances,
flow rate was significantly greater with respect to increased
augmentation with a 2.0-mL volume of inner balloon than
with a 1.0-mL volume; the same was true for a volume of
3.0 mL compared with a volume of 2.0 mL. Flow rate did
not alter in accordance with changes in augmentation with a
1.0-mL volume of inner balloon (Figure 4, A and B).
Two-way ANOVA showed that with an augmentation
level 5, a 3.0-mL volume of the inner balloon with anery c July 2014
FIGURE 3. Change in flow rate for each volume of the outside space. A, Relationship between flow rate and augmentation for each volume of outside space
using a cannula with inner diameter of 0.6 mm. B, Relationship between flow rate and augmentation for each volume of outside space using a cannula with
inner diameter of 0.8 mm. C, Relationship between percentage increase in flow rate and augmentation for each volume of outside space using a cannula
with inner diameter of 0.6 mm. D, Relationship between percentage increase in flow rate and augmentation for each volume of outside space using a cannula
with inner diameter of 0.8 mm. *Significant difference between groups from baseline at P<.01. **Significant difference between groups from baseline at
P<.001.
Kiuchi et al Evolving Technology/Basic Science
E
T
/B
Sinner diameter of 0.6 mm resulted in a significantly greater
percent increase in flow rate than did the other 2 inner
balloon volumes of 1.0 and 2.0 mL. With an augmentation
level7, an inner balloon of 3.0 mL with an inner diameter
of 0.8 mm resulted in a significantly greater percent
increase than did the other 2 inner balloon volumes of
1.0 and 2.0 mL (Figure 4, C and D).
Animal Experiment
As mentioned earlier, an 80-mL volume of outside space
and a 3.0-mL volume of the inner balloon resulted in the
greatest percent change in flow rate with respect to changes
in augmentation. To adequately encompass the flow rates
regulated with our current CAPS, we selected the booster
shunt that used an 80-mL volume of outside space and a
3.0-mL volume of the inner balloon.
Hemodynamics. No significant changes in heart rate
were found at each measurement time point. Heart rateThe Journal of Thoracic and Cawas 85.8  7.1 bpm before coronary artery ligation,
85.6  6.6 bpm at 30 minutes after, and 88.3  6.9
bpm at 60 minutes after. Likewise, no significant changes
in aortic blood pressure were seen during the 60-minute
observation period. Blood pressure was 96.3  4.2 mm
Hg before coronary artery ligation, 92.3  3.0 mm Hg
after 30 minutes, and 91.5  3.8 mm Hg after 60 minutes.
No fatal ventricular arrhythmia was observed within the
60-minute observation period in any of the pigs. Native
coronary flow was 21.8  3.3 mL/min, compared with
20.6  1.5 mL/min at the start of perfusion, 20.3  1.9
mL/min after 30 minute, and 19.9  1.7 mL/min after
60 minutes. No significant changes in flow over time
were noted. During the experiment, none of the animals
displayed disrupted hemodynamics.
The pattern of the booster shunt during the experiment
is shown in Figure 5. A flow pattern predominated in the
diastolic phase.rdiovascular Surgery c Volume 148, Number 1 307
FIGURE 4. Changes in flow rate with each volume of the inner balloon. A, Relationship between flow rate and augmentation for each volume of inner
balloon using a cannulawith inner diameter of 0.6mm. B, Relationship between flow rate and augmentation for each volume of inner balloon using a cannula
with inner diameter of 0.8 mm. C, Relationship between percentage increase in flow rate and augmentation for each inner balloon volume using a
cannula with inner diameter of 0.6 mm. D, Relationship between percentage increase in flow rate and augmentation for each inner balloon volume using
a cannula with inner diameter of 0.8 mm. *Significant difference between groups from baseline at P<.01. **Significant difference between groups from
baseline at P<.001.
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SCK-MB levels were not found to be more elevated at
each measurement time point, with 5.6  1.3 ng/mL
before the experiment, 5.7  1.2 ng/mL after 30 minutes,
and 5.7  1.4 ng/mL after 60 minutes. Negative results
for troponin T test were obtained at every measurement.
None of the patients developed myocardial ischemia as a
result of coronary perfusion using the booster shunt.
DISCUSSION
Our study suggests the potential effectiveness of the
booster shunt using a conventional IABP according to our
concept for coronary perfusion. This new device for
perfusion, with an 80-mL outside space volume and
3.0-mL inner balloon volume, was suitable to provide
coronary flow of 15 to 37 mL/min during diastole, sufficient
to prevent distal myocardial ischemia. The ability of this
booster shunt was comparable to that of the old version,
while also allowing adjustment of the perfusion rate
by augmentation of the IABP. In an animal experiment,308 The Journal of Thoracic and Cardiovascular Surghemodynamics were satisfactorily maintained, indicating
that the system is highly useful for providing cardioprotec-
tion during distal anastomosis in OPCAB.
The conventional IABP used in our study was the
Datascope CS series, the most popular IABP worldwide.
IABPs can already be found in facilities performing heart
surgery, so our system can immediately be fashioned just
by procuring the booster shunt and associated circuit.
The booster shunt has a simple structure and can be
manufactured inexpensively. Furthermore, using an exist-
ing IABP to supply power, the system is easily and readily
constructed, representing a key advantage for the new
CAPS using a booster shunt.
Several techniques have been developed to perfuse the
coronary arteries and avoid myocardial ischemia during
OPCAB. At present, the most popular technique uses an
intracoronary shunt tube.8 However, this approach may
not be able to provide adequate perfusion in patients with
low blood pressure or severe proximal coronary arteryery c July 2014
FIGURE 5. Waveform of coronary perfusion flow and electrocardiogram. A, Pattern of the coronary active perfusion system. A flow pattern predominated
in the diastolic phase (arrow). B, Electrocardiogram (ECG).
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stiff intraluminal shunt at both proximal and distal sites
can cause endothelial denudation or sometimes cause
catastrophic endothelial damage in the presence of diffuse
calcified coronary artery vessels.10 Some active perfusion
systems are thus required to provide stable flow.
Many active perfusion systems also reportedly prevent
myocardial ischemia during OPCAB. One is perfusion-
assisted direct coronary artery bypass, as described by
Cooper and colleagues.11 Another is the coronary-assisted
perfusion system of Walker and colleagues12 These
techniques provide nonpulsatile flow using a servocon-
trolled pump during anastomoses. However, these active
perfusion systems have a number of disadvantages in
that they require large, expensive, and complicated
components, so they have not yet gained widespread
acceptance among cardiac surgeons. We have previously
undertaken experimental investigations of our former
CAPS perfusion-assisted system,13 known as the SAFE
System.7
Like the other systems, our formerly employed CAPS
provides coronary flow independent of systemic blood
pressure, but differs fundamentally from other systems in
2 ways. First, the flow produced by our former CAPS is
pulsatile, synchronized with the diastolic phase of the native
cardiac cycle from the syringe pump, whereas other systems
generate a steady flow. Second, coronary perfusion pressure
stays within the physiologic range of 50 to 65 mm Hg,The Journal of Thoracic and Cawhereas other systems require suprasystemic perfusion
pressure.13 This CAPS is profoundly effective, and distal
myocardial ischemia can be avoided in many cases.7
However, the system has several disadvantages because of
its size, expense, and the difficulty of flow volume control,
like other active perfusion systems, and likewise has yet to
gain widespread acceptance among cardiac surgeons. We
therefore developed the system for a booster shunt activated
by an IABP.
During anastomosis, overperfusion can result in endothe-
lial cell damage, whereas underperfusion can lead to
myocardial ischemia.14,15 It is important to be able to
adjust blood volume in active coronary perfusion systems
to a level adequate for the artery size. To obtain this
function, we tried to change the pressure of the outside
space of the booster shunt by augmenting the IABP.
Among all 60-, 80-, and 100-mL models of the outside
space, the perfusion volume of the 80-mL model was the
most variable according to the change in augmentation.
Likewise, the 3.0-mL inner balloon was the most likely
to achieve a suitable perfusion volume among the 1.0-,
2.0- and 3.0-mL inner balloons.
Our study involved an experiment with pigs that
presented a heart rate of around 80 bpm, somewhat
faster than that normally encountered during OPCAB in
human beings. The booster shunt was able to adequately
synchronize with this heart rate and provide adequate flow
to the distal myocardium. The system maintained a flowrdiovascular Surgery c Volume 148, Number 1 309
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Incidentally, reports have indicated that flow exceeding
40 mL/min can cause intimal injury due to the increased
pressure in the coronary arteries, and can lead to signs of
myocardial edema.14,15 Larger flow may be required in
some instances, such as during bypass to treat severe
stenosis of the main trunk of the right coronary artery. In
such instances, using a cannula with a large inner
diameter allows adequate response without exceeding the
physiologic pressure inside the coronary arteries. During
anastomosis of the circumflex branch, the appropriate
coronary perfusion supplied from the active perfusion
system is useful to maintain hemodynamics.
The cannula used here was the same coronary cannula
used in our former CAPS. We have handled many
cannulae during OPCAB, but have yet to encounter fatal
vascular injuries caused by the cannula. The actual
insertion process is extremely easy and is performed very
smoothly. The cannula is designed to be useful as a suture
guide during anastomosis. The operative field can be
visualized easily by handling the cannula, and accidental
miss-stitching of the posterior coronary wall can be
prevented. The cannula includes an enlarged portion at
the tip that can also prevent back-bleeding from the
arteriotomy site by selecting a suitable size for the
individual coronary artery.7 Based on our experience, we
believe that the booster shunt, as a further development of
the above system, can be used more effectively and
conveniently than the traditional device.
Several limitations must be considered when inter-
preting our findings. The main limitation of our study
was that an in vivo animal model was used in place of
human patients. Assurance that the same results would
be observed in human patients is therefore required.
Although we used pigs with normal coronary function in
our study, we believe that a greater flow rate is necessary
in high peripheral vascular resistance conditions such as
diabetes, and that this is an important point in the clinical
setting. To confirm the effectiveness of our booster shunt
in terms of cardioprotection, access to regional wall
functions, such as by echocardiography, is thought to be
important. Furthermore, we did not have a control group
in our study and if our booster shunt offers satisfactory
cost performance remains unclear. To resolve these
issues, we plan to verify the extent of myocardial
protective effects in groups with other perfusion devices
in the future.310 The Journal of Thoracic and Cardiovascular SurgCONCLUSIONS
Our study clarified the effectiveness of a booster shunt
activated by a conventional IABP, and flow volume was
easily adjustable depending on artery size. Using this
booster shunt system, safe anastomosiswas performed in an-
imal experiments. Clinically, OPCAB can be expected to be
performed more safely and easily using this booster shunt.
The authors thank medical device specialist Hideki Takeda for
providing valuable suggestions.
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